rfhg_50962.1

Basic information about the TSS

---

TSS ID: rfhg_50962.1 Species: human Chr: chr3		Start: 141738219 End: 141738231 Strand: +
Source datasets	PRJNA401781|PRJNA615891
Protocol	CAGE|SLIC_CAGE|TIF-seq2
TSS cluster detected*	3

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3493606,EH38E2243827)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000498828.1:18 GeneID: 9616 HGNC/MGI_ID: HGNC:10070 UniProt_ID: Nearer transcript ids and distances: ENST00000480908.1:46 AK311982:46 ENST00000393000.3:66 ENST00000273480.4:67 NM_183237.3:67 NM_001201370.2:67 NM_014245.5:67 NR_037703.2:67 NR_037702.2:67 ENST00000477012.5:73 BC008627:75 BC005966:85 AF164679:86 ENST00000477393.1:88 DQ891759:102 DQ894943:102 AB590187:107 KJ892818:110 KJ898056:110 AK289894:111 BT007348:111 AF142060:111 AF312226:111 AF092878:111 ENST00000648835.1:243 view more...

Gene_name: ring finger protein 7 Gene_symbol: RNF7 Gene_synonyms: CKBBP1 RBX2 ROC2 SAG Gene_source: HGNC:10070

TATA-Box annotation

---

Distance to TSS:	16
Nearest PromoterID:	NM_001201370
Entrez ID:	9616
Nearest Unigene:	Hs.134623
Nearest Refseq:	NM_014245
Nearest Ensembl:	ENSG00000114125
Gene Name:	ring finger protein 7
Gene Alias:	CKBBP1|ROC2|SAG|rbx2
Gene Type:	protein-coding
CpG%:	0.083333
GC%:	0.692308
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RNF7 p2@RNF7 p3@RNF7 p4@RNF7
Sample		p1@RNF7	p2@RNF7	p3@RNF7	p4@RNF7
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	43.25	2.92	7.21	2.73
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	46.74	1.82	6.88	6.07
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	44.37	2.51	8.10	7.91
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	42.62	2.91	5.20	3.33
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	46.34	2.70	7.42	6.97
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	38.18	1.94	4.65	5.43
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	62.53	3.70	6.97	5.66
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	40.69	3.63	9.20	6.30
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	48.09	3.85	8.76	5.13
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	50.43	2.90	6.96	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	46.49	2.02	4.45	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	47.57	1.63	3.66	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	39.17	3.22	2.58	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.52	3.91	1.95	1.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	38.20	2.85	2.20	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	35.71	3.52	1.26	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	38.66	2.62	2.84	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	31.21	2.53	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	36.25	2.67	1.07	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.65	3.31	1.65	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	38.89	4.68	2.67	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.32	3.28	1.55	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	38.39	4.27	2.33	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.73	5.58	2.43	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	44.12	4.64	2.58	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	33.55	5.06	1.90	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	32.97	3.85	2.20	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	36.54	3.06	2.59	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	36.02	2.91	3.07	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.00	2.71	1.81	3.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	38.31	4.19	2.51	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	43.77	2.74	0.98	2.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	33.34	3.59	2.32	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	43.71	2.80	2.14	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	36.65	3.93	3.74	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	42.54	4.79	3.64	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	44.96	1.84	2.25	2.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	38.89	4.43	1.81	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	42.41	4.59	2.43	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	42.01	3.84	3.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	44.70	4.23	2.82	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	38.94	3.95	2.20	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	44.50	5.06	3.37	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	39.34	5.07	3.15	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	43.97	3.21	3.61	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	43.74	4.89	2.09	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	46.06	5.04	2.40	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	42.32	3.58	3.28	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	44.76	4.79	1.91	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	43.07	5.05	2.43	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	33.20	2.46	2.25	2.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	39.80	4.00	2.67	3.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	40.81	3.55	4.97	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	37.45	3.31	4.97	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	52.85	0.84	6.71	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	30.77	1.38	3.67	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.98	0.97	7.13	3.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	35.97	3.21	2.57	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	40.86	2.20	3.46	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.78	4.23	2.82	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.40	3.93	6.17	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.09	0.00	1.59	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	29.90	1.02	1.70	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	34.77	1.62	1.62	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	40.82	4.97	3.90	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	142.15	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	47.29	5.36	6.83	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	34.22	4.96	5.45	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	35.65	1.88	2.81	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	43.39	3.31	4.97	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	48.57	5.57	4.02	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	46.78	4.89	6.42	2.75
Adipocyte - breast, donor1	11376-118A8	68.90	5.86	3.80	2.53
Adipocyte - breast, donor2	11327-117E4	61.28	4.97	4.01	1.76
Adipocyte - omental, donor1	11473-119C6	62.72	3.69	3.05	2.29
Adipocyte - omental, donor2	11474-119C7	91.94	2.24	5.98	5.23
Adipocyte - omental, donor3	11475-119C8	94.78	3.01	1.67	4.69
Adipocyte - perirenal, donor1	11476-119C9	88.68	1.28	2.55	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	56.07	1.10	4.40	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	52.39	1.81	4.97	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	44.31	3.48	2.26	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	66.30	6.26	2.35	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	46.07	3.86	2.32	1.80
Adipocyte differentiation, day04, donor3	13025-139E1	51.57	2.23	2.51	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	61.72	1.18	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	58.47	5.07	2.65	2.01
Adipocyte differentiation, day08, donor2	13023-139D8	44.86	3.87	2.58	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	34.12	1.07	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	53.97	2.23	2.78	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	72.78	4.57	4.57	4.16
Adipocyte differentiation, day12, donor2	13024-139D9	42.20	4.27	2.76	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	41.56	2.95	2.29	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	45.98	5.48	2.13	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	82.65	5.97	5.52	6.41
Alveolar Epithelial Cells, donor2	11590-120G6	39.44	0.72	1.79	3.59
Alveolar Epithelial Cells, donor3	11671-122G6	28.75	2.40	2.40	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	76.46	2.70	2.34	3.96
Amniotic Epithelial Cells, donor2	11613-122A2	87.02	1.67	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	92.86	4.31	3.70	2.67
Anulus Pulposus Cell, donor1	11248-116E6	95.20	3.20	2.17	3.09
Anulus Pulposus Cell, donor2	11463-119B5	96.00	3.18	1.96	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	84.02	7.64	2.70	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	109.40	5.21	3.04	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	100.59	14.98	8.56	8.56
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	94.16	6.28	2.99	3.59
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	104.97	2.53	2.53	6.32
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	110.89	5.28	4.62	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	94.22	4.87	3.25	4.55
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	99.52	4.37	4.37	5.83
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	87.89	6.53	6.53	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	103.20	4.90	5.27	3.77
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	95.79	6.53	2.18	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	107.82	5.02	2.51	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	108.07	6.59	5.44	3.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	105.09	5.46	2.73	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	117.47	8.75	5.43	4.52
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	110.37	4.29	3.21	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	97.87	6.23	4.91	3.97
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	90.08	3.47	3.21	4.28
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	101.45	1.95	2.93	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	95.20	4.81	4.15	2.99
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	84.05	12.01	2.40	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	83.19	4.97	4.97	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	138.43	0.00	4.19	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	101.45	5.83	4.37	3.40
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	103.59	8.35	4.55	3.42
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	76.32	4.85	7.27	7.27
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	107.74	5.70	3.42	4.56
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	94.92	5.13	1.92	2.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	90.33	5.42	4.13	4.13
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	90.09	5.16	3.28	3.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	86.82	5.47	5.14	3.54
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	103.45	3.57	6.42	4.28
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	85.40	3.51	7.02	4.09
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	105.38	5.72	4.52	2.41
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	134.24	8.32	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	112.90	4.58	6.61	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	100.86	6.88	3.06	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	101.66	5.08	7.62	3.18
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	97.10	3.02	4.75	3.88
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	92.30	7.20	4.02	3.60
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	100.33	4.35	5.51	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	102.03	4.72	4.72	4.72
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	90.19	6.95	4.58	3.22
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	76.44	6.95	4.63	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	114.08	2.11	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	84.05	4.72	4.29	2.57
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	90.25	3.01	4.21	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	99.87	6.56	3.64	5.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	91.26	4.37	4.83	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	84.16	5.10	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	119.49	8.14	5.85	5.34
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	98.27	4.75	4.34	2.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	78.03	4.59	5.20	2.75
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	101.82	4.30	2.87	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	90.47	6.43	5.10	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	93.07	0.00	9.15	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	94.71	6.09	7.75	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	79.97	6.36	4.77	3.18
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	95.22	4.00	3.63	2.91
Astrocyte - cerebellum, donor1	11500-119F6	88.30	2.58	3.19	3.93
Astrocyte - cerebellum, donor2	11580-120F5	92.08	3.08	3.25	5.13
Astrocyte - cerebellum, donor3	11661-122F5	45.72	2.31	1.05	2.10
Astrocyte - cerebral cortex, donor1	11235-116D2	79.48	4.53	3.14	2.79
Astrocyte - cerebral cortex, donor2	11316-117D2	76.52	4.21	4.04	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	72.19	5.37	5.07	3.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	54.36	3.90	4.70	4.36
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	53.75	5.89	4.13	6.26
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	47.34	4.55	3.30	4.21
Basophils, donor1	12241-129G9	82.38	1.31	0.52	1.05
Basophils, donor2	12242-129H1	97.05	0.36	3.25	1.08
Basophils, donor3	12243-129H2	73.50	2.94	2.06	1.18
Bronchial Epithelial Cell, donor1	11511-119G8	67.91	2.59	1.51	2.37
Bronchial Epithelial Cell, donor2	11591-120G7	31.09	1.37	2.74	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	55.86	1.26	4.39	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	46.37	0.62	2.70	2.50
Bronchial Epithelial Cell, donor6	11461-119B3	59.65	1.61	2.53	2.30
Bronchial Epithelial Cell, donor7	11769-123I5	58.66	2.88	2.88	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	65.54	5.56	2.27	2.47
Burkitt's lymphoma cell line:RAJI	10476-106I8	85.24	6.29	3.26	2.33
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	115.12	1.92	0.64	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	237.86	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	77.21	1.13	1.13	1.13
CD14+ Monocytes, donor2	11305-117B9	60.88	1.11	0.56	0.74
CD14+ Monocytes, donor3	11381-118B4	59.71	1.76	1.10	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	68.21	2.26	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	53.07	1.14	1.14	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.86	0.66	0.66	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	92.37	1.88	1.16	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	66.99	1.21	1.21	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	73.67	2.61	0.95	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	49.88	1.51	1.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	39.19	2.21	2.21	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	52.56	2.73	2.48	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	46.01	1.57	1.17	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	40.24	1.25	1.07	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	85.31	2.61	1.74	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	39.10	0.47	1.40	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	40.66	1.06	2.64	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	43.26	5.55	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	70.06	2.53	1.34	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	61.46	1.20	2.00	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	87.65	3.96	2.71	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	37.52	1.83	0.46	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	37.55	0.00	1.13	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.35	2.18	0.87	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	62.67	2.15	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	62.81	2.44	0.87	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	71.96	2.52	1.68	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	29.21	1.29	0.55	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	28.18	0.70	1.76	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	27.20	1.75	1.75	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	44.99	1.74	1.74	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	46.09	1.49	1.86	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	73.07	1.94	3.45	2.16
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	34.81	1.64	0.82	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	26.19	1.16	0.46	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	29.93	0.70	0.70	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	88.93	1.53	0.87	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	92.63	0.69	1.15	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	110.47	0.87	1.52	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	119.44	1.71	1.40	1.56
CD14+CD16- Monocytes, donor2	11799-124C8	117.19	2.10	1.40	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	86.96	1.56	0.89	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	137.79	0.77	0.51	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	105.61	1.10	1.10	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	109.06	1.26	1.05	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	130.07	2.03	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	120.00	2.03	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	101.49	1.04	1.04	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	102.34	2.13	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	112.04	1.07	2.14	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	107.40	2.81	2.81	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	119.22	3.92	0.00	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	135.78	3.95	0.00	3.95
CD19+ B Cells, donor1	11544-120B5	78.08	1.64	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	87.05	2.90	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	72.69	1.01	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	37.98	1.21	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	38.35	1.60	0.40	1.20
CD34+ Progenitors, donor1	11545-120B6	105.43	4.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	137.64	1.69	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	67.26	3.76	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	88.39	2.93	1.13	2.48
CD4+ T Cells, donor1	11225-116C1	113.90	2.14	0.71	1.07
CD4+ T Cells, donor2	11306-117C1	93.69	1.22	0.00	1.84
CD4+ T Cells, donor3	11382-118B5	95.46	1.22	0.91	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	92.14	1.28	0.77	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	88.49	1.80	1.35	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	92.56	2.30	0.57	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	193.90	1.42	0.00	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	184.71	1.40	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	145.03	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	103.04	0.72	0.87	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	83.55	2.54	1.19	2.37
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	78.51	3.06	0.48	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	140.77	2.24	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	165.61	1.75	0.00	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	102.08	0.00	0.88	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	80.11	0.00	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	70.64	1.45	1.04	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	89.21	1.34	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	115.84	1.90	0.54	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	129.70	0.00	1.61	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	100.42	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	90.12	1.48	0.74	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	79.07	1.52	1.08	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	88.26	1.05	0.84	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	161.79	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	142.97	1.73	1.73	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	99.37	0.87	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	154.40	2.47	0.99	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	161.56	2.77	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	194.02	4.19	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	152.03	1.38	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	136.68	0.49	0.98	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	160.16	0.00	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	127.85	1.43	1.43	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	174.51	0.00	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	92.33	2.29	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	97.99	1.13	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	106.05	1.77	0.25	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	28.67	2.75	1.38	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.44	2.88	1.44	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.43	1.64	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	30.62	3.00	1.20	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.16	1.92	1.44	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.01	0.68	0.68	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	26.07	1.09	2.39	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.69	1.05	2.37	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	21.34	1.41	0.70	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.47	1.51	2.72	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	29.05	2.03	0.87	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.44	2.13	2.13	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	13.57	0.88	1.75	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.50	1.37	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	1.49	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	32.77	0.72	1.44	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.47	4.03	2.01	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	22.39	2.59	2.12	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.94	2.54	0.63	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.99	3.69	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	23.72	1.92	2.24	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	31.74	1.53	1.91	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	27.59	4.73	2.36	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	30.26	1.51	3.03	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	61.02	2.41	1.61	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	45.46	3.50	1.40	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	44.08	2.00	7.01	6.01
Cardiac Myocyte, donor1	11525-119I4	51.18	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	78.56	0.49	0.99	2.96
Cardiac Myocyte, donor3	11686-122I3	55.04	3.16	2.00	2.00
Chondrocyte - de diff, donor1	11261-116G1	62.40	2.77	1.73	3.12
Chondrocyte - de diff, donor2	11338-117F6	60.06	4.26	2.13	2.13
Chondrocyte - de diff, donor3	11410-118E6	67.47	3.75	2.62	1.37
Chondrocyte - re diff, donor2	11339-117F7	98.48	1.79	1.79	1.79
Chondrocyte - re diff, donor3	11411-118E7	69.56	6.47	4.85	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	107.99	4.25	3.33	4.13
Ciliary Epithelial Cells, donor2	11323-117D9	85.51	5.34	3.63	4.49
Ciliary Epithelial Cells, donor3	11399-118D4	98.50	5.75	4.60	5.40
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	62.91	4.77	7.70	7.15
Corneal Epithelial Cells, donor1	11526-119I5	61.70	2.42	1.98	1.54
Corneal Epithelial Cells, donor2	11606-120I4	68.26	2.28	4.55	2.28
Corneal Epithelial Cells, donor3	11687-122I4	70.30	2.30	1.79	2.81
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	66.20	3.14	1.32	1.65
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	70.97	2.84	1.58	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	64.04	2.70	2.38	1.40
Dendritic Cells - plasmacytoid, donor1	11228-116C4	120.60	3.76	0.00	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	147.55	9.79	2.61	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	170.35	1.94	0.97	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	61.20	1.50	2.33	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	58.09	4.11	1.17	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	50.62	1.70	1.98	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	62.52	3.93	3.93	1.57
Endothelial Cells - Artery, donor1	11264-116G4	58.17	2.91	1.75	2.04
Endothelial Cells - Artery, donor2	11341-117F9	52.23	3.29	1.88	2.35
Endothelial Cells - Artery, donor3	11413-118E9	58.03	2.98	2.45	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	95.75	7.98	4.88	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	96.76	7.91	2.74	2.74
Endothelial Cells - Lymphatic, donor3	11393-118C7	61.45	1.69	3.38	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	78.15	1.49	1.78	2.38
Endothelial Cells - Microvascular, donor2	11342-117G1	109.34	2.08	1.56	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	63.38	3.83	0.99	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	96.83	1.20	1.60	2.80
Endothelial Cells - Thoracic, donor2	11343-117G2	52.41	1.05	1.57	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	114.06	3.60	3.60	3.11
Endothelial Cells - Umbilical vein, donor2	11324-117E1	82.34	3.04	1.96	2.39
Endothelial Cells - Umbilical vein, donor3	11400-118D5	76.82	3.91	2.20	1.95
Endothelial Cells - Vein, donor1	11267-116G7	56.88	3.41	0.00	4.55
Endothelial Cells - Vein, donor2	11344-117G3	49.59	1.40	4.19	1.40
Endothelial Cells - Vein, donor3	11416-118F3	76.15	1.73	2.51	2.51
Eosinophils, donor1	12244-129H3	121.98	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	69.31	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	53.02	1.95	1.95	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	68.65	0.00	4.16	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	58.70	4.11	2.87	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	47.85	3.07	2.63	1.86
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	61.75	2.49	1.63	1.52
Fibroblast - Aortic Adventitial, donor1	11245-116E3	76.16	3.40	3.52	3.88
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	33.98	2.87	2.59	1.91
Fibroblast - Aortic Adventitial, donor2	11326-117E3	59.70	4.11	2.74	1.37
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.55	0.53	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	62.12	1.66	2.66	2.99
Fibroblast - Cardiac, donor1	11268-116G8	63.51	1.81	2.27	1.81
Fibroblast - Cardiac, donor2	11345-117G4	57.60	3.03	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	71.13	5.52	2.37	2.68
Fibroblast - Cardiac, donor4	11452-119A3	60.62	3.94	1.52	1.82
Fibroblast - Cardiac, donor5	11456-119A7	106.47	1.78	3.30	1.65
Fibroblast - Cardiac, donor6	11460-119B2	83.07	2.58	3.79	3.94
Fibroblast - Choroid Plexus, donor1	11492-119E7	94.73	0.80	2.81	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	65.15	3.88	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	71.77	8.79	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	116.24	3.23	5.54	5.07
Fibroblast - Conjunctival, donor3	11692-122I9	93.62	1.70	1.36	1.19
Fibroblast - Dermal, donor1	11269-116G9	71.84	3.76	3.99	3.52
Fibroblast - Dermal, donor2	11346-117G5	72.17	2.36	4.72	2.36
Fibroblast - Dermal, donor3	11418-118F5	91.03	6.17	3.51	3.14
Fibroblast - Dermal, donor4	11450-119A1	92.25	2.15	5.09	4.41
Fibroblast - Dermal, donor5	11454-119A5	109.03	3.84	8.02	5.58
Fibroblast - Dermal, donor6	11458-119A9	102.49	3.09	6.33	6.66
Fibroblast - Gingival, donor1	11237-116D4	87.04	3.96	3.33	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	84.63	3.41	3.14	2.88
Fibroblast - Gingival, donor2	11318-117D4	95.15	7.25	5.93	5.01
Fibroblast - Gingival, donor3	11394-118C8	67.87	3.29	2.51	2.42
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	66.49	3.12	1.04	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	53.92	4.41	2.64	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	73.89	5.14	5.30	4.21
Fibroblast - Gingival, donor6 (control)	11922-125H5	82.08	3.79	5.95	4.60
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	15.17	2.82	1.41	2.12
Fibroblast - Gingival, donor7 (control)	11924-125H7	73.85	5.41	4.53	4.68
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	69.13	3.27	4.91	3.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	74.81	4.72	4.17	4.17
Fibroblast - Gingival, donor9 (control)	11927-125I1	64.71	2.49	2.93	2.49
Fibroblast - Lung, donor1	11270-116H1	32.62	0.00	5.44	1.36
Fibroblast - Lung, donor2	11347-117G6	58.19	1.49	1.49	2.98
Fibroblast - Lung, donor3	11419-118F6	65.84	5.70	5.06	2.95
Fibroblast - Lymphatic, donor1	11506-119G3	91.63	0.83	1.67	5.83
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	2.80	8.39	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	40.58	0.56	1.96	0.84
Fibroblast - Mammary, donor1	11540-120B1	92.56	3.25	6.09	5.68
Fibroblast - Mammary, donor2	11620-122A9	67.90	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	90.97	5.04	5.82	6.01
Fibroblast - Periodontal Ligament, donor2	11319-117D5	72.81	3.64	4.25	2.58
Fibroblast - Periodontal Ligament, donor3	11395-118C9	59.06	3.67	4.90	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	62.20	3.05	4.58	2.67
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	97.20	5.40	3.78	4.05
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	58.80	3.83	3.60	1.39
Fibroblast - Pulmonary Artery, donor1	11250-116E8	84.56	5.53	4.31	2.54
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	75.99	4.27	5.69	3.25
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	60.81	2.67	4.01	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	97.26	5.93	4.74	3.56
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	28.77	0.40	1.98	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	68.74	2.31	3.55	3.20
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	65.43	4.14	4.14	2.56
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	35.80	0.60	0.90	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	93.81	1.94	2.48	2.91
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	37.96	0.51	1.77	1.01
Fibroblast - skin normal, donor1	11553-120C5	89.75	4.76	3.94	2.30
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	28.27	1.60	0.40	2.61
Fibroblast - skin normal, donor2	11561-120D4	100.66	1.71	4.22	3.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	32.94	0.91	1.81	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	87.40	5.47	3.31	1.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	95.73	0.85	1.88	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.27	0.33	1.31	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	114.40	3.52	5.97	5.33
Fibroblast - skin walker warburg, donor1	11554-120C6	83.16	3.88	4.22	5.57
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	78.25	4.08	3.76	1.73
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	243.76	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	59.26	0.00	0.87	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	82.69	5.20	5.20	3.81
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	59.07	4.42	4.68	5.47
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	57.49	5.88	4.85	3.32
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	143.92	9.95	9.95	6.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	146.76	7.66	7.66	7.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	164.31	13.41	9.13	9.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	93.21	7.72	3.03	6.89
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	101.15	6.16	4.57	3.20
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	131.16	10.90	10.10	6.34
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	98.33	5.29	3.70	4.49
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	108.28	8.15	4.89	4.89
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	154.78	17.69	11.06	11.50
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	121.40	8.90	5.79	7.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	111.81	6.28	3.82	5.66
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	91.33	5.91	6.72	6.45
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	92.42	4.71	4.83	5.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	98.56	4.15	3.88	8.03
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	82.95	4.88	7.93	5.90
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	91.73	5.25	3.42	3.65
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	101.40	3.11	3.61	4.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	93.55	5.25	4.59	3.72
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	97.80	5.61	4.14	4.14
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	89.97	3.18	2.38	4.29
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	83.56	5.59	3.80	5.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	86.10	2.42	2.42	2.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	95.17	2.88	3.90	2.88
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	86.99	3.19	3.19	2.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.36	2.60	2.29	1.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	67.46	1.20	1.88	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	102.47	3.65	4.20	2.43
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	91.43	2.83	2.25	2.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	81.26	1.84	2.45	2.45
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	97.58	3.51	3.09	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	95.58	4.15	1.38	2.19
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	86.55	3.67	1.67	2.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	81.56	3.31	1.76	1.54
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	104.42	3.32	1.97	2.71
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	84.13	4.70	2.92	2.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	101.03	2.57	2.25	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	88.69	3.03	1.99	3.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	77.66	2.85	3.16	2.85
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	70.85	2.13	1.52	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	91.78	1.57	3.35	2.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	83.21	3.51	4.83	2.85
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	63.97	4.21	3.65	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	78.24	2.69	2.22	2.87
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	87.17	3.21	3.21	3.21
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	79.41	2.60	2.91	2.45
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	94.82	3.37	3.76	3.11
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	93.52	3.52	3.25	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	88.49	4.06	2.40	2.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	84.00	3.07	2.63	3.07
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	55.54	1.98	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	89.30	4.88	2.51	2.51
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	79.90	4.44	3.03	2.62
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	44.22	2.03	1.27	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	134.17	3.58	6.77	7.96
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	109.55	7.09	4.78	6.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	132.77	6.75	2.25	5.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	149.89	9.39	7.82	5.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	159.93	10.17	7.06	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	98.24	6.00	5.53	6.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	111.37	9.90	4.95	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	116.43	8.90	3.87	4.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	96.27	6.42	4.81	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	128.67	3.48	3.48	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	108.38	5.53	6.51	7.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	109.54	5.35	5.35	3.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	86.64	0.00	3.33	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	100.39	8.39	6.71	4.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	111.78	5.23	3.92	6.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	104.85	3.36	5.03	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	125.96	6.68	5.73	7.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	101.22	5.43	7.13	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	183.76	10.44	4.18	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	135.73	4.58	5.15	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	100.34	9.18	5.92	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	147.39	10.16	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	140.42	7.04	7.46	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	99.42	5.29	4.83	6.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	126.44	5.27	15.81	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	107.64	5.00	2.31	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	129.74	5.22	7.17	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	207.34	14.05	8.69	6.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	136.38	6.55	6.55	6.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	152.00	7.19	9.24	6.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	139.15	2.48	4.97	12.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	173.17	12.27	9.44	5.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	125.53	3.62	6.64	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	138.87	9.16	4.07	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	126.03	5.98	6.78	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	154.42	8.88	6.91	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	171.16	10.62	10.62	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	152.86	5.25	6.42	5.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	154.05	7.90	6.58	6.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	127.15	6.78	6.78	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	124.76	4.78	5.37	7.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	127.62	7.28	1.94	4.37
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	62.77	1.14	6.85	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	55.72	4.16	3.33	6.24
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	79.84	1.12	3.37	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	62.80	2.54	2.85	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	68.09	2.92	2.92	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	67.42	5.45	4.64	5.45
Hep-2 cells mock treated, biol_rep2	11899-125E9	64.31	5.57	4.73	4.90
Hep-2 cells mock treated, biol_rep3	11900-125F1	58.24	4.32	3.87	4.78
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	64.38	5.25	5.03	4.70
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	62.54	4.08	4.51	4.51
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	52.53	3.66	5.38	3.66
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	75.84	6.60	3.11	4.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	61.59	4.29	3.43	3.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	58.63	3.52	2.88	3.52
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	159.49	6.16	6.16	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	56.70	3.03	2.60	3.46
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	80.42	3.53	2.82	5.29
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	66.11	1.45	6.54	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	70.81	3.67	4.37	2.80
Hepatocyte, donor1	11523-119I2	42.37	4.84	1.21	2.42
Hepatocyte, donor2	11603-120I1	50.63	3.23	2.15	1.08
Hepatocyte, donor3	11684-122I1	36.81	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	84.20	2.61	1.31	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	73.23	4.19	1.57	2.62
Iris Pigment Epithelial Cells, donor1	11530-119I9	68.47	5.08	6.45	4.25
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	3.18	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	40.15	1.38	1.38	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	5.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	9.14	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	50.35	1.62	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	35.01	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	33.09	3.97	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	31.04	2.22	0.00	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	49.76	5.04	1.26	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	44.58	1.29	0.65	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	43.47	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	40.74	1.63	3.26	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	45.76	1.26	0.42	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	48.22	3.21	0.00	4.82
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	36.01	2.77	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	55.23	2.83	0.94	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	29.93	2.72	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	52.73	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	50.82	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	43.36	2.55	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	49.21	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	43.56	2.14	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	50.31	1.54	1.54	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	0.00	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	29.21	2.78	1.39	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	2.21	2.21	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	0.00	6.48	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	48.83	0.00	0.87	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	2.25	4.50	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	45.87	1.07	0.00	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	31.87	1.39	4.16	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	0.00	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	38.66	1.84	3.68	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	72.61	6.05	0.00	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	37.01	1.06	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	42.76	3.43	2.04	2.37
Keratinocyte - epidermal, donor2	11349-117G8	48.61	0.59	1.17	2.34
Keratinocyte - epidermal, donor3	11421-118F8	60.86	4.64	2.75	1.61
Keratinocyte - oral, donor1	11251-116E9	94.22	3.52	2.95	1.82
Keratocytes, donor1	11527-119I6	161.26	6.19	3.78	2.75
Keratocytes, donor2	11607-120I5	71.48	3.52	5.86	4.69
Keratocytes, donor3	11688-122I5	73.70	4.35	2.37	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	96.71	6.59	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	74.43	2.16	5.39	3.24
Lens Epithelial Cells, donor2	11609-120I7	85.46	5.19	3.81	2.19
Lens Epithelial Cells, donor3	11690-122I7	63.27	4.04	2.02	3.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	66.17	2.96	2.85	2.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	50.51	3.07	1.12	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	64.70	1.57	2.52	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	51.08	3.23	3.23	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	59.88	1.26	0.95	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	71.80	3.45	2.48	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	57.87	3.28	2.46	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	65.48	2.78	1.26	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	64.60	3.10	1.97	1.69
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	62.10	4.35	1.58	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	55.26	1.74	1.94	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	64.99	2.41	2.04	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	68.29	1.05	3.14	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	50.33	2.15	2.15	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	68.40	3.16	1.37	1.79
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	68.06	2.46	2.46	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	46.14	1.25	2.49	1.87
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	63.13	2.38	3.66	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	64.83	2.96	2.30	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	48.03	1.76	1.46	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	53.02	1.74	2.24	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	54.32	3.39	3.39	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	54.13	1.08	3.23	1.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	70.69	2.57	1.82	1.67
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	53.91	0.52	2.07	4.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	51.51	4.19	3.35	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	63.61	2.86	2.26	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	63.97	6.19	1.38	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	53.43	2.26	1.51	1.88
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	59.69	2.54	1.48	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	66.87	1.94	2.91	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	53.26	1.98	1.98	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	61.95	2.35	1.12	1.86
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	71.82	2.96	4.44	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	54.61	1.48	2.22	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	63.66	2.06	2.06	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	66.58	1.93	2.57	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	50.52	2.43	1.22	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	67.74	3.36	1.82	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	68.27	2.13	3.20	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	47.51	0.97	3.39	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	54.77	1.87	2.18	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	83.08	5.01	3.94	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	47.69	0.98	1.63	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	53.44	3.77	1.88	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	72.15	3.47	2.35	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	42.52	2.56	1.54	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	56.99	0.60	1.79	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	83.84	6.80	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	64.44	6.14	3.84	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	63.09	2.97	2.97	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	61.78	1.69	2.54	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	64.71	4.22	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	63.51	1.87	1.87	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	54.10	4.64	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	77.31	0.00	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	86.63	3.85	1.13	2.71
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	78.81	4.65	3.20	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	75.18	4.50	0.90	3.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	78.72	3.79	3.12	3.93
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	54.43	3.08	1.03	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	83.63	4.23	1.41	2.82
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	60.63	4.66	5.33	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	74.88	4.58	3.06	5.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	86.18	5.07	3.20	4.54
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	88.80	4.35	3.97	3.78
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	76.08	4.29	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	65.23	6.52	3.26	5.71
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	88.50	3.75	2.92	3.33
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	94.45	3.36	3.64	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	77.28	3.09	5.15	4.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	83.03	4.64	3.19	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	96.55	3.29	2.39	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	70.82	3.32	1.11	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	61.15	3.89	1.77	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	73.39	4.06	2.58	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	86.35	4.61	2.30	4.61
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	78.67	6.14	2.30	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	60.58	2.83	2.26	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	73.02	4.92	1.64	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	61.00	2.26	3.62	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	61.76	2.87	0.72	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	74.69	2.99	2.24	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	59.08	2.97	1.49	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	73.23	3.45	2.58	4.31
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	77.07	2.57	3.43	4.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	71.30	4.33	2.00	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	65.16	3.62	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	63.99	5.69	3.55	4.27
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	65.99	5.16	1.03	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	67.09	3.76	2.68	3.76
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	59.93	4.71	1.35	4.04
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	74.08	5.19	2.96	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	100.01	1.16	0.00	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	66.64	1.06	2.12	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	70.83	4.80	0.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	60.33	5.81	1.45	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	75.12	4.60	3.07	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	67.09	5.92	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	51.75	1.88	1.88	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	73.41	3.02	2.01	4.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	65.34	4.96	1.80	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	56.80	1.72	3.44	8.61
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	75.26	3.56	3.12	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	62.56	3.52	2.35	3.13
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	67.95	6.60	3.96	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	77.84	1.56	3.11	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	53.82	1.75	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	69.89	3.91	1.68	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	69.34	4.86	1.32	5.30
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	68.66	3.86	3.47	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	69.88	3.04	1.01	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	72.57	3.36	2.88	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	77.12	3.18	3.58	2.39
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	71.70	5.47	0.61	7.29
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	71.25	0.00	1.38	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	69.54	4.18	5.70	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	69.72	1.55	2.07	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	75.58	1.21	1.81	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	76.06	2.85	1.58	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	77.30	3.20	3.20	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	83.33	2.30	2.87	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	65.31	6.69	1.54	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	75.69	1.41	2.12	5.66
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	77.18	2.27	2.84	3.40
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	71.56	4.99	2.91	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	68.91	3.13	1.57	7.05
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	77.66	2.92	1.25	5.01
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	71.09	5.58	1.86	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	69.58	2.68	2.68	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	74.85	0.53	0.53	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	56.57	2.42	5.25	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	78.93	5.51	1.84	4.59
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	76.46	4.45	1.78	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	62.12	5.13	1.71	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	69.79	3.83	4.60	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	62.93	2.19	4.38	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	59.69	4.01	4.45	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	75.13	7.54	2.08	4.16
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	82.89	1.99	4.64	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	64.44	2.08	6.24	2.08
Macrophage - monocyte derived, donor1	11232-116C8	54.93	2.05	1.37	0.68
Macrophage - monocyte derived, donor2	11313-117C8	44.78	2.39	1.28	1.28
Macrophage - monocyte derived, donor3	11389-118C3	58.20	2.62	1.57	1.31
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	137.53	13.81	9.56	8.50
Mallassez-derived cells, donor2	11929-125I3	85.09	2.54	4.44	3.64
Mallassez-derived cells, donor3	11930-125I4	88.40	3.75	6.12	4.17
Mammary Epithelial Cell, donor1	11273-116H4	106.82	3.99	3.79	4.38
Mammary Epithelial Cell, donor2	11350-117G9	71.52	2.61	2.90	2.61
Mammary Epithelial Cell, donor3	11422-118F9	31.68	3.49	2.99	1.75
Mast cell - stimulated, donor1	11487-119E2	96.27	2.71	2.03	0.00
Mast cell, donor1	11563-120D6	58.50	0.65	0.65	0.43
Mast cell, donor2	11565-120D8	35.96	1.49	0.00	0.30
Mast cell, donor3	11566-120D9	56.06	0.90	0.90	1.13
Mast cell, donor4	11567-120E1	32.98	0.71	0.35	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	80.51	1.55	1.44	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	48.45	0.58	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	93.38	0.46	1.03	0.69
Mast cell, expanded, donor8	11941-126A6	35.98	0.33	0.17	0.67
Melanocyte - dark, donor1	11502-119F8	79.50	1.89	3.08	1.49
Melanocyte - dark, donor2	11582-120F7	73.72	2.08	2.08	2.08
Melanocyte - dark, donor3	11663-122F7	51.58	2.54	1.74	1.52
Melanocyte - light, donor1	11274-116H5	23.98	0.47	0.94	1.18
Melanocyte - light, donor2	11351-117H1	23.89	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	34.69	0.87	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	51.75	1.98	1.77	2.60
Melanocyte, donor2 (MC+2)	12739-135I3	54.60	2.15	1.61	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	58.12	1.61	1.34	1.07
Meningeal Cells, donor1	11493-119E8	111.28	1.98	5.21	6.45
Meningeal Cells, donor2	11573-120E7	89.35	2.20	3.96	3.52
Meningeal Cells, donor3	11654-122E7	82.24	2.85	3.10	3.83
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	100.09	3.71	3.99	6.56
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	75.78	5.13	3.12	2.82
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	31.54	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	51.02	0.00	3.92	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	60.28	7.89	8.61	5.74
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	84.92	8.26	4.87	4.02
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	96.01	10.05	5.03	3.52
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	72.30	2.42	4.83	4.83
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	73.06	2.19	5.11	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	78.57	3.48	4.91	4.71
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	98.20	0.69	1.39	2.49
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	44.98	1.49	1.49	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	62.10	3.68	1.05	2.24
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	57.27	1.48	1.48	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	70.44	6.40	3.84	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	103.85	7.09	8.86	5.32
Mesenchymal stem cells - hepatic, donor0	11218-116B3	75.68	3.13	0.94	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	84.18	6.53	5.08	7.98
Mesothelial Cells, donor1	11247-116E5	94.40	11.40	4.77	4.24
Mesothelial Cells, donor2	12156-128G5	120.61	11.01	7.51	7.01
Mesothelial Cells, donor3	11402-118D7	70.02	8.53	5.35	3.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	35.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	51.96	1.97	2.22	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	53.30	4.71	2.65	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	49.28	1.86	2.17	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	45.84	2.07	1.87	1.66
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	37.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	55.81	1.75	1.50	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	43.76	3.72	2.79	2.33
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	55.68	2.03	1.83	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	44.35	2.38	1.98	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	38.05	0.88	3.54	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	50.91	2.66	2.28	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	47.37	1.32	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	33.11	1.91	1.91	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	1.84	1.84	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.14	1.79	1.19	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	1.68	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	30.86	3.26	0.75	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	31.61	1.90	2.38	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	30.96	0.55	1.66	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.33	1.84	2.07	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	30.92	2.10	1.47	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.99	1.22	0.82	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	33.68	1.50	1.07	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.23	1.56	0.89	1.56
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	19.49	1.97	0.88	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	23.32	1.52	1.52	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	0.00	1.66	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.68	1.63	0.82	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	27.35	2.65	2.35	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	17.45	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.51	1.92	1.92	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	34.42	4.00	2.40	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	0.00	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.52	1.50	3.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	31.53	0.44	2.19	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	0.00	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	0.64	0.64	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	32.23	2.73	1.98	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	29.92	0.70	1.39	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	48.55	3.08	3.08	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	38.95	2.19	0.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	35.15	0.71	0.71	2.13
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	50.78	6.17	2.52	2.52
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	56.53	2.49	3.74	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	43.12	1.75	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	42.23	1.21	1.21	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	49.25	3.76	1.67	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	36.94	2.77	3.69	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	62.60	2.28	1.71	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	42.28	1.11	1.11	1.93
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	53.90	3.37	2.33	4.66
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	55.34	3.86	3.00	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	39.38	2.54	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	37.90	4.00	1.87	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	61.96	4.49	5.69	3.59
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	40.26	1.55	1.27	1.55
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	61.47	4.78	3.82	3.19
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	63.02	2.43	3.76	3.10
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	53.09	0.76	1.14	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	49.72	1.99	4.26	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	66.37	2.95	4.92	3.93
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	42.36	2.61	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	50.57	2.35	1.47	4.70
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	70.64	2.88	2.88	2.88
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	46.57	1.65	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	43.77	1.19	2.08	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	64.16	3.56	1.78	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	51.91	1.97	0.99	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	45.23	2.10	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	51.79	1.78	0.79	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	57.74	1.86	2.79	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	58.96	2.25	1.50	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	45.28	2.40	2.13	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	57.46	1.81	1.81	1.24
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	50.10	0.74	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	58.99	1.83	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	45.11	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	67.87	2.67	1.07	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	37.37	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	44.69	2.11	2.11	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	91.25	1.36	4.09	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	59.13	1.91	1.91	3.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	73.70	2.43	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	60.42	6.04	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	108.49	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	6.52	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	90.70	4.96	4.09	4.52
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	72.64	2.09	2.61	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	27.37	2.00	8.01	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	33.39	2.50	4.17	2.92
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	44.30	3.04	1.90	2.28
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	97.35	4.79	4.79	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	27.20	6.80	4.76	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	55.13	3.68	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	32.65	3.35	2.93	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	48.58	4.18	5.58	3.25
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	34.05	2.70	2.70	3.78
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	52.56	3.57	2.31	3.57
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	34.74	1.49	3.97	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	47.10	2.71	2.17	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	36.72	2.72	1.59	2.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	37.72	1.96	3.27	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	54.86	1.09	1.09	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	40.84	4.24	2.12	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	28.81	3.60	1.80	3.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	33.47	2.30	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	28.30	1.79	1.46	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	54.68	2.12	1.41	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	27.43	4.92	4.22	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	29.88	0.92	1.84	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	40.17	3.86	3.53	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	38.63	2.41	2.76	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	47.23	3.12	2.01	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.45	2.12	1.69	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	34.42	1.19	1.19	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	47.65	5.15	2.58	3.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	37.99	3.00	2.00	2.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	41.93	3.61	3.16	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	36.90	3.97	1.98	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	37.15	4.64	4.64	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	52.97	2.65	3.78	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	31.94	1.30	3.91	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	29.20	1.31	1.74	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	50.20	2.71	3.17	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	36.16	5.29	0.88	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	0.66	2.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	36.21	4.96	1.98	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	29.09	2.30	3.45	4.21
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.41	1.51	1.21	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.07	3.98	2.43	2.43
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	34.56	6.10	5.42	5.42
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	5.11	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	45.12	4.88	2.44	2.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	33.68	3.46	3.78	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.00	3.33	1.82	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	38.77	2.37	5.54	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	38.54	0.00	4.53	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	106.22	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	85.34	8.07	5.22	4.35
Myoblast, donor2	11322-117D8	78.06	4.79	1.73	2.49
Myoblast, donor3	11398-118D3	65.08	4.04	3.87	3.03
NK T cell leukemia cell line:KHYG-1	10777-110G3	52.68	1.46	1.46	0.73
Natural Killer Cells, donor1	11230-116C6	98.41	0.92	0.92	0.62
Natural Killer Cells, donor2	11311-117C6	92.28	1.81	0.60	0.00
Natural Killer Cells, donor3	11387-118C1	87.98	1.47	0.92	0.55
Neural stem cells, donor1	11275-116H6	64.24	2.18	2.18	2.54
Neural stem cells, donor2	11352-117H2	75.10	3.85	7.70	5.78
Neurons, donor1	11494-119E9	81.93	6.83	4.55	4.55
Neurons, donor2	11574-120E8	55.92	4.18	1.98	3.52
Neurons, donor3	11655-122E8	74.82	8.22	3.29	2.47
Neutrophils, donor1	11233-116C9	23.20	0.00	0.93	0.93
Neutrophils, donor2	11314-117C9	20.29	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	32.99	1.22	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	68.51	2.26	1.42	1.66
Nucleus Pulposus Cell, donor2	11409-118E5	69.03	3.91	0.98	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	99.88	1.80	3.41	3.61
Olfactory epithelial cells, donor1	11933-125I7	73.37	4.96	2.89	2.89
Olfactory epithelial cells, donor2	11934-125I8	80.33	4.92	2.46	1.30
Olfactory epithelial cells, donor3	11935-125I9	67.54	3.63	4.20	2.84
Olfactory epithelial cells, donor4	11936-126A1	55.91	3.21	2.53	2.05
Oligodendrocyte - precursors, donor1	11496-119F2	60.18	6.62	8.43	2.41
Osteoblast - differentiated, donor1	11276-116H7	48.71	2.13	2.13	1.06
Osteoblast - differentiated, donor2	11353-117H3	51.44	3.43	2.29	2.29
Osteoblast - differentiated, donor3	11425-118G3	70.14	5.59	2.48	1.86
Osteoblast, donor1	11277-116H8	73.09	3.32	2.93	2.74
Osteoblast, donor2	11354-117H4	67.42	4.21	6.32	2.11
Osteoblast, donor3	11426-118G4	78.73	5.87	5.15	3.38
Pancreatic stromal cells, donor1	11249-116E7	85.08	4.21	2.61	4.13
Pericytes, donor1	11491-119E6	63.09	0.67	1.67	1.78
Pericytes, donor2	11571-120E5	97.34	2.49	3.40	1.58
Pericytes, donor3	11652-122E5	78.74	4.48	5.90	3.26
Perineurial Cells, donor1	11499-119F5	63.74	4.18	3.16	3.05
Perineurial Cells, donor2	11579-120F4	77.93	3.96	3.31	3.04
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	94.98	2.55	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	65.38	0.73	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	70.01	1.94	0.91	0.00
Placental Epithelial Cells, donor1	11278-116H9	71.03	4.07	2.63	2.39
Placental Epithelial Cells, donor2	11355-117H5	74.30	4.44	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	51.83	3.34	0.79	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	60.44	3.80	6.01	4.43
Preadipocyte - breast, donor1	11467-119B9	60.40	2.63	2.44	3.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.97	1.04	0.52	0.65
Preadipocyte - breast, donor2	11328-117E5	79.03	4.28	3.83	3.60
Preadipocyte - omental, donor1	11468-119C1	68.94	3.73	3.09	3.41
Preadipocyte - omental, donor2	11329-117E6	70.27	3.49	2.62	3.93
Preadipocyte - omental, donor3	11403-118D8	67.90	7.45	5.16	3.58
Preadipocyte - perirenal, donor1	11469-119C2	92.52	0.98	2.95	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	61.12	2.76	3.99	3.07
Preadipocyte - subcutaneous, donor2	11356-117H6	78.98	4.96	6.91	7.44
Preadipocyte - subcutaneous, donor3	11428-118G6	103.19	5.45	9.88	4.43
Preadipocyte - visceral, donor1	11280-116I2	79.18	5.31	4.84	4.75
Preadipocyte - visceral, donor2	11357-117H7	67.65	3.22	5.52	4.60
Preadipocyte - visceral, donor3	11429-118G7	96.03	3.76	7.31	6.48
Prostate Epithelial Cells (polarized), donor1	11253-116F2	68.03	1.66	1.81	1.81
Prostate Epithelial Cells, donor2	11331-117E8	52.00	3.93	2.84	2.57
Prostate Epithelial Cells, donor3	11404-118D9	30.07	3.98	1.78	1.41
Prostate Stromal Cells, donor1	11254-116F3	72.78	5.70	4.56	4.44
Prostate Stromal Cells, donor2	11332-117E9	61.14	5.20	5.20	2.87
Prostate Stromal Cells, donor3	11405-118E1	66.53	5.21	3.34	2.82
Renal Cortical Epithelial Cells, donor1	11516-119H4	68.25	3.28	2.92	2.92
Renal Cortical Epithelial Cells, donor2	11596-120H3	65.36	3.33	4.92	5.34
Renal Epithelial Cells, donor1	11517-119H5	49.71	3.04	2.54	4.06
Renal Epithelial Cells, donor2	11597-120H4	75.40	2.85	5.69	3.56
Renal Epithelial Cells, donor3	11678-122H4	76.54	4.98	4.23	4.55
Renal Glomerular Endothelial Cells, donor1	11514-119H2	156.60	7.49	8.17	5.45
Renal Glomerular Endothelial Cells, donor2	11594-120H1	129.10	5.26	7.14	5.53
Renal Glomerular Endothelial Cells, donor3	11675-122H1	79.92	4.44	5.55	4.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	36.60	0.67	2.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	70.21	3.74	5.72	4.84
Renal Mesangial Cells, donor2	11598-120H5	76.49	3.13	3.13	6.27
Renal Mesangial Cells, donor3	11679-122H5	48.27	3.05	3.88	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	82.67	4.83	9.66	8.59
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	60.72	2.11	4.22	5.06
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	72.90	4.44	7.33	5.79
Retinal Pigment Epithelial Cells, donor0	11215-116A9	88.16	6.74	7.00	7.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	124.50	6.82	4.26	6.82
Retinal Pigment Epithelial Cells, donor2	11608-120I6	65.86	2.06	10.29	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	70.51	3.01	3.76	3.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.43	4.54	1.60	2.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	55.39	1.79	1.79	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	42.93	0.55	1.10	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	43.50	0.00	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	79.45	1.43	4.94	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	78.05	2.88	4.67	4.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	83.54	4.13	3.57	5.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	97.13	4.09	6.08	4.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	83.68	4.08	4.66	5.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	88.29	3.93	5.78	5.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	69.14	1.92	4.52	4.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	71.55	3.03	3.78	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	92.28	2.15	5.38	5.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	80.05	1.15	4.45	6.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	83.28	3.11	3.86	5.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	92.49	6.42	3.76	4.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	63.85	0.76	5.16	4.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	76.95	4.47	4.29	3.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	78.55	3.95	5.45	6.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	77.24	1.33	5.44	4.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	75.63	3.41	4.48	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	85.93	4.39	5.35	5.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	76.04	2.03	4.91	5.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	69.80	2.80	5.33	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	82.54	3.93	4.27	5.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	75.30	1.64	5.83	5.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	77.38	4.54	6.13	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	106.78	3.76	7.12	8.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	86.57	0.47	7.31	7.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	77.78	3.77	5.16	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	95.41	4.44	6.08	6.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	84.60	1.04	5.18	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	85.83	1.77	4.42	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	83.55	6.06	6.89	5.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	86.00	1.75	6.73	7.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	76.80	4.09	3.92	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	86.95	4.05	6.36	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	84.94	2.92	5.33	8.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	73.93	3.84	4.12	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	82.74	3.61	4.43	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	63.23	1.53	3.92	5.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	82.71	3.55	5.62	4.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	61.57	2.40	5.33	5.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	65.54	0.83	3.73	4.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	96.91	4.76	7.14	6.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	71.75	4.03	4.43	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	78.64	1.70	4.80	4.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	73.72	6.29	2.45	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	62.86	1.81	1.21	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	76.98	1.71	3.30	4.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	87.77	2.18	2.91	5.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	73.01	3.65	3.65	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	77.46	2.41	3.62	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	58.13	1.36	2.04	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	59.61	1.80	1.50	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	61.40	0.59	2.13	3.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	67.66	2.77	4.06	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	59.50	3.00	1.20	1.20
Schwann Cells, donor1	11498-119F4	81.25	1.88	4.89	3.01
Schwann Cells, donor2	11578-120F3	34.02	6.80	0.00	3.40
Schwann Cells, donor3	11659-122F3	75.80	1.97	3.72	5.92
Sebocyte, donor1	11220-116B5	50.94	1.64	3.83	4.38
Sebocyte, donor2	11301-117B5	45.04	1.84	2.76	3.22
Sebocyte, donor3	11378-118B1	37.31	3.09	1.65	1.65
Sertoli Cells, donor1	11255-116F4	59.64	9.94	3.31	1.66
Sertoli Cells, donor2	11333-117F1	39.54	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	55.69	3.87	2.20	1.14
Skeletal Muscle Cells, donor2	11358-117H8	45.54	2.17	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	73.57	5.85	3.34	3.34
Skeletal Muscle Cells, donor4	11451-119A2	86.72	5.34	6.60	6.44
Skeletal Muscle Cells, donor5	11455-119A6	86.51	3.12	5.65	4.01
Skeletal Muscle Cells, donor6	11459-119B1	92.50	2.92	7.70	6.93
Skeletal Muscle Satellite Cells, donor1	11240-116D7	103.07	3.91	3.02	3.78
Skeletal Muscle Satellite Cells, donor2	11321-117D7	86.47	3.00	3.85	3.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	81.25	7.54	6.05	5.56
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	78.69	4.30	3.20	2.70
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	66.59	2.17	4.34	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	97.56	3.99	2.75	1.93
Skin - palm, donor1	10286-104F7	110.13	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.87	2.31	1.01	1.87
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	2.45	4.91	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	28.69	2.60	2.08	1.30
Small Airway Epithelial Cells, donor1	11256-116F5	61.30	2.64	3.48	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	48.25	2.53	2.25	1.83
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	45.88	2.33	1.90	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	36.73	4.12	1.05	1.50
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	83.63	3.09	7.41	5.25
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	22.01	0.22	1.33	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	76.42	9.41	5.29	4.70
Smooth Muscle Cells - Aortic, donor1	11283-116I5	45.08	2.65	2.43	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	75.21	3.54	8.27	4.73
Smooth Muscle Cells - Aortic, donor3	11432-118H1	76.48	5.41	1.55	6.95
Smooth Muscle Cells - Bladder, donor1	11519-119H7	74.06	0.00	2.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	70.13	4.13	4.13	1.86
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	91.10	3.55	6.65	3.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	122.27	3.71	4.74	2.82
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	88.23	5.86	3.91	5.21
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	79.74	6.20	6.20	3.54
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	71.32	10.11	5.13	4.56
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	61.82	4.72	5.37	6.51
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	49.93	2.44	1.22	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	52.03	2.53	0.25	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	62.47	2.38	4.77	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	75.80	3.69	4.72	3.24
Smooth Muscle Cells - Colonic, donor2	11320-117D6	74.04	2.37	3.87	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	80.61	6.72	5.46	4.30
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	75.02	6.03	5.26	3.40
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	83.00	6.47	6.47	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	76.81	4.18	5.08	3.29
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	61.45	3.41	1.02	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	78.53	2.28	1.73	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	69.14	3.72	3.62	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	88.52	6.83	6.14	3.41
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	94.19	2.42	4.23	5.43
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	76.30	7.68	6.09	8.48
Smooth Muscle Cells - Prostate, donor1	11257-116F6	68.18	2.66	3.20	3.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	67.74	3.51	4.76	3.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	60.88	0.76	2.28	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	74.63	3.17	3.02	2.71
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	60.76	2.25	2.25	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	59.44	5.17	2.58	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	63.25	4.65	2.33	1.86
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	71.19	6.06	4.54	4.54
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	89.32	5.33	4.07	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	60.77	4.72	2.95	4.42
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	68.39	3.33	3.58	4.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	64.94	5.61	0.00	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	93.55	6.48	5.18	3.89
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	100.45	7.14	6.37	3.57
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	92.51	4.89	2.82	2.82
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	60.37	6.01	4.89	4.75
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	74.15	4.44	5.53	3.52
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	43.81	0.95	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	101.78	6.36	3.43	3.18
Smooth Muscle Cells - Uterine, donor1	11258-116F7	73.35	3.76	4.86	5.52
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.32	3.51	3.22	2.93
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	44.70	0.39	1.36	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	53.42	3.44	4.76	1.85
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	43.89	1.12	2.60	2.98
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	61.45	5.03	4.31	3.95
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	81.76	10.79	7.67	4.26
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	53.57	1.18	6.30	3.54
Smooth muscle cells - airway, control, donor1	11966-126D4	50.28	2.54	1.52	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	47.92	3.59	2.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	59.36	4.60	2.09	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	55.46	1.83	1.83	1.38
Synoviocyte, donor1	11291-117A4	66.49	3.03	5.55	2.19
Synoviocyte, donor2	11368-117I9	70.07	2.85	1.34	1.68
Synoviocyte, donor3	11440-118H9	72.38	0.22	1.12	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	72.18	2.86	6.43	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	67.39	0.00	1.98	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	62.52	1.16	1.62	2.32
Tracheal Epithelial Cells, donor1	11292-117A5	50.39	2.37	2.80	2.44
Tracheal Epithelial Cells, donor2	11369-118A1	45.23	2.32	3.48	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	45.24	3.44	2.86	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	71.72	3.44	1.85	2.34
Urethra, donor2	10319-105A4	62.94	1.80	5.40	0.00
Urothelial Cells, donor1	11520-119H8	46.76	3.45	1.86	2.66
Urothelial Cells, donor2	11600-120H7	54.88	2.80	0.40	2.00
Urothelial Cells, donor3	11681-122H7	41.72	1.83	2.06	0.69
Urothelial cells, donor0	11216-116B1	63.53	2.90	2.90	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	46.27	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	60.04	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	39.02	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	55.44	0.69	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	70.89	0.00	1.74	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	55.19	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	55.99	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	49.30	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	90.18	3.95	3.08	2.84
Wilms' tumor cell line:HFWT	10597-108E3	49.28	0.88	4.40	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	74.58	1.68	1.96	3.91
achilles tendon, donor2	10292-104G4	57.86	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	74.70	3.82	2.55	3.31
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	62.22	3.25	0.70	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	92.24	2.37	2.61	2.73
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	87.35	7.07	4.35	6.26
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	69.99	2.81	3.65	2.53
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	74.44	1.27	1.90	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	65.33	0.82	0.00	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	94.74	2.64	2.64	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	70.65	2.04	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	94.36	4.27	2.72	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	57.41	2.58	1.47	2.58
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	0.00	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	55.31	1.63	1.16	2.32
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	78.19	2.59	1.81	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	67.22	2.05	1.75	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	73.90	0.93	0.93	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	55.11	1.23	1.23	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	29.16	0.92	1.53	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	66.57	3.41	2.99	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	64.90	4.85	1.82	3.03
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	71.25	3.85	1.44	4.33
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	53.23	2.00	1.34	2.23
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	43.36	3.34	2.00	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	1.86	7.43	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	61.77	2.64	3.77	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	47.97	0.87	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	101.50	4.47	3.53	2.35
adipose tissue, adult, pool1	10010-101C1	40.02	1.09	0.47	0.78
adipose, donor1	10184-103D4	139.57	5.86	5.86	6.45
adipose, donor2	10185-103D5	105.03	8.11	2.43	5.68
adipose, donor3	10186-103D6	100.47	3.54	2.72	3.00
adipose, donor4	10187-103D7	148.21	7.80	6.93	9.53
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	48.29	6.31	2.21	2.21
adrenal gland, adult, pool1	10081-102A9	54.57	10.91	0.00	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	64.57	4.00	3.60	4.14
alveolar cell carcinoma cell line:SW 1573	10708-109H6	42.88	3.22	1.43	1.79
amniotic membrane cells, donor1	12235-129G3	70.71	4.41	3.25	3.71
amniotic membrane cells, donor2	12236-129G4	84.86	4.73	3.72	3.72
amniotic membrane cells, donor3	12237-129G5	73.94	4.12	2.06	5.30
amygdala - adult, donor10196	10167-103B5	43.87	3.56	3.56	4.74
amygdala, adult, donor10252	10151-102I7	46.23	5.07	1.42	2.03
amygdala, newborn, donor10223	10360-105E9	51.64	2.26	2.58	3.87
anaplastic carcinoma cell line:8305C	10428-106D5	74.74	4.46	1.78	2.04
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	86.93	7.28	5.29	5.74
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	68.81	2.34	1.67	0.67
aorta, adult, pool1	10052-101G7	66.29	3.33	2.16	1.96
appendix, adult	10189-103D9	45.02	3.49	2.33	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	87.02	4.47	4.47	5.85
artery, adult	10190-103E1	118.21	6.79	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	99.38	3.04	2.03	1.30
b cell line:RPMI1788	10427-106D4	179.19	8.62	5.20	6.84
basal cell carcinoma cell line:TE 354.T	10702-109G9	90.73	6.66	7.49	3.61
bile duct carcinoma cell line:HuCCT1	10432-106D9	96.65	2.98	6.35	5.56
bile duct carcinoma cell line:TFK-1	10496-107C1	104.44	7.03	1.67	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	94.51	2.24	3.36	1.12
bladder, adult, pool1	10011-101C2	61.93	2.82	0.98	1.20
blood, adult, pool1	10053-101G8	77.51	4.43	8.86	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	61.66	1.71	4.28	1.71
bone marrow, adult	10192-103E3	50.61	1.35	0.67	0.00
brain, adult, donor1	10084-102B3	31.78	1.03	3.08	2.05
brain, adult, pool1	10012-101C3	38.86	3.12	0.89	1.56
brain, fetal, pool1	10085-102B4	88.16	5.34	2.67	5.34
breast carcinoma cell line:MCF7	10482-107A5	92.83	2.97	0.99	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	53.05	2.25	0.75	1.25
breast, adult, donor1	10080-102A8	49.25	2.53	2.53	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	98.33	5.21	2.79	2.16
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	69.88	2.78	2.78	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	102.68	10.82	8.06	10.82
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	86.18	5.08	1.69	3.39
carcinoid cell line:NCI-H1770	10703-109H1	34.32	2.35	1.88	1.88
carcinoid cell line:NCI-H727	10735-110B6	64.86	1.31	1.31	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	40.25	1.58	3.49	5.39
carcinosarcoma cell line:JHUCS-1	10642-109A3	52.70	2.40	3.19	3.73
caudate nucleus - adult, donor10196	10177-103C6	61.02	4.61	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	56.56	7.53	2.84	2.51
caudate nucleus, adult, donor10258	10379-105H1	97.05	7.64	1.53	6.11
caudate nucleus, newborn, donor10223	10354-105E3	82.77	3.66	3.66	1.83
cerebellum - adult, donor10196	10173-103C2	55.35	5.83	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	53.59	8.11	2.14	2.56
cerebellum, adult, pool1	10083-102B2	51.40	4.83	1.03	2.41
cerebellum, newborn, donor10223	10357-105E6	59.78	2.49	0.83	3.32
cerebral meninges, adult	10188-103D8	66.31	3.28	2.02	0.25
cerebrospinal fluid, donor2	10294-104G6	79.67	6.58	3.65	0.00
cervical cancer cell line:D98-AH2	10552-107I3	89.58	4.31	1.87	2.01
cervical cancer cell line:ME-180	10553-107I4	81.04	3.31	1.66	1.82
cervix, adult, pool1	10013-101C4	57.32	2.20	0.73	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	66.33	3.48	1.39	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	92.74	2.61	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	56.30	4.35	2.11	1.99
choriocarcinoma cell line:SCH	10785-110H2	91.92	4.56	2.59	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	98.43	6.64	3.32	4.27
chorionic membrane cells, donor1	12238-129G6	50.15	3.13	1.99	2.85
chorionic membrane cells, donor2	12239-129G7	94.06	11.43	6.36	5.67
chorionic membrane cells, donor3	12240-129G8	67.59	1.10	4.40	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	91.89	4.04	2.02	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	69.92	1.92	1.73	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	42.24	0.21	0.21	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	62.66	3.08	1.80	3.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	57.81	3.14	2.18	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	48.46	3.46	3.26	2.44
chronic myelogenous leukemia cell line:K562	10454-106G4	58.60	5.01	2.06	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	40.40	0.52	0.78	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	63.09	4.34	3.20	2.74
clear cell carcinoma cell line:TEN	10636-108I6	59.17	3.12	2.95	2.43
colon carcinoma cell line:CACO-2	10513-107D9	91.70	2.01	1.10	2.93
colon carcinoma cell line:COLO-320	10420-106C6	109.46	4.56	2.66	3.80
colon, adult, donor1	10082-102B1	83.30	5.95	2.38	2.38
colon, adult, pool1	10014-101C5	73.91	3.41	1.41	2.00
colon, fetal, donor1	10070-101I7	79.72	3.09	2.47	1.85
common myeloid progenitor CMP, donor1	12130-128D6	68.75	4.58	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	61.62	3.82	3.40	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	41.81	3.62	1.36	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	38.36	1.55	1.83	1.27
corpus callosum, adult, pool1	10042-101F6	42.35	2.99	0.66	1.11
cruciate ligament, donor2	10295-104G7	51.06	0.00	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	80.26	4.82	2.41	0.80
diencephalon, adult	10193-103E4	39.36	3.60	3.12	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	59.93	1.38	2.07	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	76.68	2.56	3.59	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	45.26	4.33	4.09	5.06
ductus deferens, adult	10196-103E7	70.76	2.99	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	73.45	5.76	4.32	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.21	0.74	2.21	0.74
dura mater, adult, donor1	10041-101F5	70.36	1.98	1.49	1.40
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	49.97	2.89	2.22	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	47.14	1.86	4.59	4.30
embryonic pancreas cell line:1B2C6	10604-108F1	79.54	4.93	3.70	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	60.54	5.15	3.94	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	53.10	3.40	1.85	1.23
embryonic pancreas cell line:2C6	10603-108E9	65.67	5.25	3.94	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	99.55	7.37	5.70	4.02
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	92.61	10.87	3.44	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	67.70	5.79	6.91	6.91
epidermoid carcinoma cell line:A431	10426-106D3	96.04	3.56	3.11	2.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	57.96	5.17	2.42	1.54
epididymis, adult	10197-103E8	73.26	2.30	2.72	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	48.61	2.48	4.08	3.19
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	43.26	2.36	0.79	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	72.73	6.68	1.83	2.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	54.52	5.02	1.77	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	76.96	7.62	3.36	2.80
esophagus, adult, pool1	10015-101C6	61.05	2.23	1.17	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	61.49	4.26	0.88	0.88
eye - muscle inferior rectus, donor1	10272-104E2	94.17	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	101.00	8.42	2.10	0.00
eye - muscle medial, donor2	10299-104H2	86.32	4.46	4.46	0.00
eye - muscle superior, donor2	10297-104G9	74.52	3.44	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	48.09	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	70.93	4.07	1.27	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	98.73	5.00	3.33	3.08
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	86.90	9.50	7.36	6.41
frontal lobe, adult, pool1	10040-101F4	44.94	3.85	1.31	2.35
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	119.20	3.00	3.90	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	53.12	3.29	1.55	2.29
gall bladder, adult	10198-103E9	74.12	3.86	0.97	1.45
gamma delta positive T cells, donor1	11937-126A2	90.73	1.07	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	97.11	3.36	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	52.59	0.84	1.69	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	118.95	3.87	1.93	2.13
gastric cancer cell line:AZ521	10549-107H9	66.07	8.20	5.74	6.39
gastric cancer cell line:GSS	10560-108A2	79.62	5.49	2.75	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	110.57	2.97	2.06	2.51
giant cell carcinoma cell line:LU65	10487-107B1	93.28	3.79	2.29	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	78.80	2.10	3.78	7.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	73.33	4.24	2.24	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	56.05	3.38	4.01	3.69
glioblastoma cell line:A172, tech_rep2	10444-106F3	52.24	4.63	5.06	3.51
glioblastoma cell line:T98G	10485-107A8	53.75	3.31	2.76	2.65
glioma cell line:GI-1	10413-106B8	41.88	1.17	2.05	1.17
globus pallidus - adult, donor10196	10175-103C4	56.13	5.10	3.64	1.46
globus pallidus, adult, donor10252	10161-103A8	45.89	8.30	2.44	3.17
globus pallidus, adult, donor10258	10367-105F7	35.60	2.74	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	47.43	5.33	3.20	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	110.12	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	153.00	21.86	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	130.66	5.23	0.00	10.45
granulosa cell tumor cell line:KGN	10624-108H3	48.00	3.84	4.16	1.92
hIPS +CCl2, biol_rep1	14383-156B9	104.68	2.30	11.02	5.97
hIPS +CCl2, biol_rep2	14384-156C1	98.77	0.46	5.03	9.15
hIPS +CCl2, biol_rep3	14385-156C2	119.16	2.58	9.66	14.17
hIPS, biol_rep1	14380-156B6	81.93	0.00	11.50	5.75
hIPS, biol_rep2	14381-156B7	103.57	2.74	10.97	8.23
hIPS, biol_rep3	14382-156B8	56.28	2.21	3.31	4.41
hairy cell leukemia cell line:Mo	10712-109I1	49.42	2.87	3.45	3.74
heart - mitral valve, adult	10205-103F7	47.83	2.09	0.60	1.49
heart - pulmonic valve, adult	10206-103F8	60.40	3.14	1.83	0.78
heart - tricuspid valve, adult	10207-103F9	54.12	5.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	61.63	5.31	2.45	2.65
heart, adult, diseased, donor1	10051-101G6	64.73	4.26	2.98	3.41
heart, adult, pool1	10016-101C7	79.34	6.21	1.15	1.84
heart, fetal, pool1	10046-101G1	66.64	2.98	1.64	2.26
hepatic mesenchymal tumor cell line:LI90	10778-110G4	58.62	7.71	5.24	3.09
hepatoblastoma cell line:HuH-6	10633-108I3	99.89	2.38	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	67.73	8.73	2.98	4.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	70.28	9.47	4.85	2.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	64.78	7.98	3.84	3.84
hepatoma cell line:Li-7	10484-107A7	61.39	2.34	1.33	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	113.77	4.22	5.43	5.13
hippocampus - adult, donor10196	10169-103B7	50.16	1.89	2.84	1.89
hippocampus, adult, donor10252	10153-102I9	43.27	5.10	2.25	1.02
hippocampus, adult, donor10258	10374-105G5	41.33	0.50	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	46.53	1.76	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	157.47	12.21	12.82	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	111.14	10.41	5.30	6.28
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	119.08	8.63	7.62	4.57
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	93.04	4.51	5.64	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	70.23	4.39	2.07	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	111.61	1.90	4.93	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	100.43	4.09	2.92	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	92.20	7.76	4.09	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	101.77	3.75	1.25	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	140.65	6.39	3.32	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	104.14	5.95	2.57	2.57
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	153.51	3.37	2.69	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	107.97	10.95	7.04	6.26
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	104.15	7.37	8.35	6.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	143.13	7.85	10.47	5.24
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	87.44	7.45	5.35	4.96
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	73.70	3.05	3.92	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	91.96	4.50	3.00	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	103.43	5.46	4.33	5.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	114.59	8.18	4.55	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	125.61	4.70	3.45	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	118.72	3.76	3.76	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	116.99	4.64	2.61	3.48
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	130.33	4.48	3.29	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	111.22	10.16	8.87	7.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	120.10	12.27	9.13	5.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	178.84	13.47	5.31	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	81.33	4.58	3.52	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	80.45	3.17	3.17	4.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	107.73	5.75	4.54	5.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	74.98	5.17	6.72	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	85.01	1.33	2.66	7.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	110.57	4.62	3.08	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	110.44	3.58	2.30	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	111.31	6.06	0.76	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	132.74	4.03	5.04	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	114.47	6.76	5.80	7.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	142.61	9.80	4.90	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	130.73	11.22	7.80	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	71.82	3.67	3.36	6.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	227.73	0.00	22.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	104.25	2.32	5.63	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	89.21	7.66	2.19	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	91.56	6.88	3.26	5.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	94.31	4.63	2.49	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	78.76	0.00	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	111.05	5.42	3.25	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	109.91	4.04	4.04	2.69
immature langerhans cells, donor1	11904-125F5	69.74	2.42	1.70	4.12
immature langerhans cells, donor2	11905-125F6	52.28	1.58	0.79	0.79
insula, adult, pool1	10039-101F3	54.70	5.11	1.99	2.18
keratoacanthoma cell line:HKA-1	10791-110H8	123.88	12.03	8.78	8.13
kidney, adult, pool1	10017-101C8	57.07	3.10	1.50	1.80
kidney, fetal, pool1	10045-101F9	60.76	2.97	1.20	1.70
large cell lung carcinoma cell line:IA-LM	10509-107D5	79.53	2.56	3.83	3.12
large cell lung carcinoma cell line:NCI-H460	10839-111E2	53.22	2.76	0.41	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	53.21	3.85	1.83	1.10
left atrium, adult, donor1	10079-102A7	53.40	2.72	2.18	1.63
left ventricle, adult, donor1	10078-102A6	59.67	3.54	1.01	1.01
leiomyoblastoma cell line:G-402	10721-110A1	55.27	3.56	3.28	1.64
leiomyoma cell line:10964C	10569-108B2	85.50	6.47	4.67	3.95
leiomyoma cell line:15242A	10570-108B3	92.39	5.98	7.61	7.07
leiomyoma cell line:15425	10571-108B4	67.99	1.94	3.40	6.31
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	32.41	2.09	3.14	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	85.83	2.01	2.36	2.01
liposarcoma cell line:KMLS-1	10782-110G8	79.35	5.78	4.22	3.91
liposarcoma cell line:SW 872	10726-110A6	66.28	4.14	1.46	3.90
liver, adult, pool1	10018-101C9	45.38	3.57	1.62	2.11
liver, fetal, pool1	10086-102B5	26.34	1.88	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	33.83	4.67	0.87	1.02
locus coeruleus, adult, donor10252	10165-103B3	39.31	7.94	2.03	1.66
locus coeruleus, adult, donor10258	10375-105G6	36.11	2.54	1.69	2.54
locus coeruleus, newborn, donor10223	10362-105F2	30.28	1.68	1.26	0.84
lung adenocarcinoma cell line:A549	10499-107C4	60.62	3.32	2.21	2.35
lung adenocarcinoma cell line:PC-14	10408-106B3	66.87	0.69	1.38	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	76.19	2.90	3.82	2.50
lung, adult, pool1	10019-101D1	49.85	2.72	1.06	0.83
lung, fetal, donor1	10068-101I5	75.92	0.29	1.71	2.28
lung, right lower lobe, adult, donor1	10075-102A3	54.99	4.12	1.37	2.75
lymph node, adult, donor1	10077-102A5	43.55	2.84	0.00	1.89
lymphangiectasia cell line:DS-1	10727-110A7	51.29	2.63	2.19	2.63
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	66.56	2.57	2.26	2.72
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	129.97	2.55	0.85	3.40
mature adipocyte, donor1	12231-129F8	65.71	2.66	0.89	0.89
mature adipocyte, donor2	12232-129F9	52.92	1.45	0.83	0.21
mature adipocyte, donor3	12233-129G1	50.02	1.90	0.95	1.19
mature adipocyte, donor4	12234-129G2	53.70	2.63	0.26	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	83.39	2.62	1.43	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	47.38	4.51	4.51	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	32.00	4.05	1.10	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	38.12	1.59	1.59	3.81
medial frontal gyrus, newborn, donor10223	10352-105E1	59.71	2.99	4.26	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	47.76	4.22	2.70	2.53
medial temporal gyrus, adult, donor10252	10156-103A3	37.78	2.55	1.49	2.12
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	25.04	0.00	3.85	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	58.15	3.59	2.87	2.51
medulla oblongata - adult, donor10196	10174-103C3	46.08	3.24	1.95	0.65
medulla oblongata, adult, donor10252	10155-103A2	40.56	6.04	2.01	1.08
medulla oblongata, adult, pool1	10038-101F2	45.14	3.35	0.98	1.88
medulla oblongata, newborn, donor10223	10361-105F1	56.59	2.43	2.08	1.04
medulloblastoma cell line:D283 Med	10838-111E1	62.88	0.89	1.11	2.44
medulloblastoma cell line:ONS-76	10759-110E3	51.97	3.79	2.32	2.45
melanoma cell line:COLO 679	10514-107E1	47.15	2.87	1.87	2.30
melanoma cell line:G-361	10465-106H6	53.21	1.36	3.26	2.17
meningioma cell line:HKBMM	10691-109F7	61.87	3.08	1.99	2.53
merkel cell carcinoma cell line:MKL-1	10843-111E6	46.70	0.88	2.64	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	66.36	2.07	2.07	3.89
mesenchymal precursor cell - adipose, donor1	11747-123G1	116.76	3.99	6.75	6.60
mesenchymal precursor cell - adipose, donor2	11748-123G2	69.44	4.00	3.27	1.64
mesenchymal precursor cell - adipose, donor3	11749-123G3	82.82	1.66	5.38	4.14
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	70.52	3.51	4.21	1.69
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	78.76	3.66	4.04	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	81.21	6.25	6.25	6.25
mesenchymal precursor cell - cardiac, donor1	11752-123G6	68.14	4.98	3.43	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	64.18	2.42	3.34	2.88
mesenchymal precursor cell - cardiac, donor3	11754-123G8	91.78	4.77	5.84	4.91
mesenchymal precursor cell - cardiac, donor4	11755-123G9	81.16	5.27	4.59	3.24
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	92.04	5.83	7.97	3.41
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	71.80	3.29	2.63	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	78.87	4.57	5.95	3.87
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	86.92	3.49	7.33	4.89
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	86.57	4.49	6.53	2.25
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	63.98	6.11	5.75	5.39
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	71.90	3.00	4.34	2.59
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	51.53	7.98	5.47	2.96
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	85.59	9.23	4.20	8.39
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	91.75	4.63	4.48	4.03
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	92.61	5.25	5.51	3.59
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	51.91	3.31	5.15	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	58.09	7.15	6.30	3.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	81.68	2.53	3.79	3.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	75.35	2.74	2.74	4.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	62.16	5.37	2.81	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	62.04	3.66	2.62	4.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	63.16	4.62	2.16	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	59.07	4.00	1.41	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	68.03	3.38	2.37	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	49.91	2.75	2.36	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	68.58	2.32	3.24	3.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	68.93	2.60	2.88	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	57.78	3.57	2.23	3.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	71.14	2.88	3.61	2.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	56.47	0.00	2.20	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	63.77	2.01	3.02	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	65.09	3.28	1.64	3.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	57.13	2.15	0.43	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	82.03	0.00	2.73	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	46.48	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	76.97	2.60	2.92	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	88.75	1.45	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	89.56	2.13	5.33	6.93
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	73.60	2.45	3.27	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	76.97	5.83	3.89	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	54.57	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	76.50	3.97	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	57.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	65.23	3.56	0.59	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	65.80	1.22	1.22	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	89.94	0.00	1.27	3.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	83.81	1.38	2.07	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	66.63	6.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	75.84	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	79.21	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	76.60	2.04	1.63	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	72.29	2.38	2.38	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	63.08	2.95	2.36	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	65.15	4.05	1.25	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	64.16	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	47.31	5.91	1.18	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	68.84	2.75	5.51	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	83.13	8.91	6.93	8.41
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	76.26	8.97	3.36	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	78.87	11.45	3.82	6.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	97.92	10.48	8.46	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	102.49	6.54	10.90	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	89.96	8.87	7.60	6.34
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	69.19	4.86	3.03	5.46
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	85.86	9.04	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	83.19	8.24	6.59	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	75.40	4.17	2.78	1.98
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	68.14	2.92	3.57	2.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	49.91	6.11	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	70.41	3.09	1.55	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	71.58	10.39	4.96	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	142.71	9.04	3.71	2.78
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	76.92	8.55	4.27	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	84.15	2.98	6.27	4.32
mesothelioma cell line:Mero-25	10850-111F4	80.11	4.77	1.36	2.27
mesothelioma cell line:Mero-41	10851-111F5	43.52	3.18	3.18	5.87
mesothelioma cell line:Mero-48a	10852-111F6	49.82	3.32	5.76	3.54
mesothelioma cell line:Mero-82	10853-111F7	65.44	4.47	4.73	2.37
mesothelioma cell line:Mero-83	10854-111F8	50.04	1.70	2.72	2.38
mesothelioma cell line:Mero-84	10855-111F9	91.50	3.29	4.30	5.06
mesothelioma cell line:Mero-95	10856-111G1	44.51	1.86	2.28	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	37.93	2.32	2.82	3.31
mesothelioma cell line:NCI-H226	10846-111E9	67.15	1.81	2.90	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	78.24	3.42	3.59	2.90
mesothelioma cell line:NCI-H28	10845-111E8	64.13	2.54	2.04	3.82
mesothelioma cell line:No36	10857-111G2	54.15	3.59	3.26	4.89
mesothelioma cell line:ONE58	10858-111G3	84.81	6.50	5.69	6.23
migratory langerhans cells, donor1	11901-125F2	41.84	1.15	1.54	1.34
migratory langerhans cells, donor2	11902-125F3	35.17	0.61	1.34	0.49
migratory langerhans cells, donor3	11903-125F4	47.02	0.54	0.72	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	41.46	5.55	1.63	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	76.72	3.81	3.39	2.97
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	80.39	2.53	3.23	2.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	58.04	2.28	2.28	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	67.08	3.70	2.22	1.85
myeloma cell line:PCM6	10474-106I6	123.54	6.72	1.38	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	65.95	2.03	2.03	3.04
myxofibrosarcoma cell line:NMFH-1	10684-109E9	40.80	2.16	2.16	2.16
nasal epithelial cells, donor1, tech_rep1	12226-129F3	52.82	4.46	2.12	2.79
nasal epithelial cells, donor1, tech_rep2	12226-129F3	57.44	4.41	1.84	2.06
nasal epithelial cells, donor2	12227-129F4	68.45	1.10	3.86	1.10
neuroblastoma cell line:CHP-134	10508-107D4	110.66	7.36	2.53	3.68
neuroblastoma cell line:NB-1	10539-107G8	90.74	5.61	4.86	3.37
neuroblastoma cell line:NBsusSR	10607-108F4	59.68	2.95	1.48	1.69
neuroblastoma cell line:NH-12	10555-107I6	93.92	4.10	3.91	2.42
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	57.88	1.66	1.42	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	46.56	3.01	0.95	2.38
neuroectodermal tumor cell line:TASK1	10774-110F9	145.51	5.23	7.25	5.84
neuroepithelioma cell line:SK-N-MC	10728-110A8	82.65	3.81	6.36	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	59.09	1.60	1.60	3.19
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	73.23	1.69	0.34	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	87.26	6.40	3.20	8.01
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	81.75	4.17	2.24	3.85
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	96.17	4.73	5.78	3.68
nucleus accumbens, adult, pool1	10037-101F1	58.02	3.56	2.34	3.28
occipital cortex - adult, donor10196	10172-103C1	39.15	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	40.52	4.29	0.81	1.07
occipital cortex, newborn, donor10223	10355-105E4	49.50	2.91	2.91	0.73
occipital lobe, adult, donor1	10076-102A4	53.53	1.57	1.57	2.10
occipital lobe, fetal, donor1	10073-102A1	89.68	5.58	3.00	6.01
occipital pole, adult, pool1	10036-101E9	38.24	2.60	0.87	1.18
olfactory region, adult	10195-103E6	37.64	1.15	2.10	1.91
optic nerve, donor1	10277-104E7	46.02	0.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	86.46	3.76	3.19	1.82
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	80.92	3.02	2.47	3.43
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	95.67	3.56	3.39	3.89
oral squamous cell carcinoma cell line:SAS	10544-107H4	86.52	3.35	3.12	3.35
osteoclastoma cell line:Hs 706.T	10704-109H2	65.85	2.06	3.53	2.94
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	109.32	4.67	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	58.74	5.94	2.54	2.33
ovary, adult, pool1	10020-101D2	50.31	2.88	1.40	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.70	5.50	1.28	2.02
pancreas, adult, donor1	10049-101G4	94.06	3.76	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	84.42	3.35	1.96	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	58.60	1.87	1.53	2.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	39.08	0.99	0.66	1.49
paracentral gyrus, adult, pool1	10035-101E8	43.20	2.93	1.01	1.65
parietal cortex, adult, donor10258	10373-105G4	53.58	1.47	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	36.68	3.76	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	33.35	2.85	0.57	1.43
parietal lobe, adult, pool1	10034-101E7	42.91	2.56	0.97	1.94
parietal lobe, fetal, donor1	10072-101I9	90.19	5.82	1.94	1.94
parietal lobe, newborn, donor10223	10356-105E5	56.45	2.24	2.24	4.11
parotid gland, adult	10199-103F1	62.90	3.08	0.62	0.62
penis, adult	10200-103F2	53.71	4.30	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	61.54	3.35	1.12	2.42
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	123.69	2.77	2.91	2.91
pineal gland - adult, donor10196	10179-103C8	62.57	2.58	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	69.88	4.74	0.59	2.96
pineal gland, adult, donor10258	10377-105G8	43.27	1.88	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	98.14	6.07	9.11	10.12
pituitary gland, adult, donor10252	10162-103A9	97.46	11.99	8.86	4.17
pituitary gland, adult, donor10258	10378-105G9	111.51	9.36	8.51	5.96
placenta, adult, pool1	10021-101D3	63.43	3.55	1.83	3.44
plasma cell leukemia cell line:ARH-77	10840-111E3	46.22	1.99	1.99	1.85
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	55.72	3.58	2.80	3.58
pons, adult, pool1	10033-101E6	36.58	2.15	1.20	1.81
postcentral gyrus, adult, pool1	10032-101E5	45.42	3.84	1.31	2.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	104.57	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	143.21	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	152.56	11.74	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	85.65	7.28	3.79	5.83
prostate cancer cell line:PC-3	10439-106E7	71.33	7.08	5.08	6.17
prostate, adult, pool1	10022-101D4	69.20	2.18	1.00	1.27
putamen, adult, donor10196	10176-103C5	55.24	7.55	2.60	4.49
putamen, adult, donor10252	10152-102I8	96.08	5.88	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	44.81	2.19	1.09	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	76.83	7.25	2.66	2.17
putamen, newborn, donor10223	10365-105F5	50.23	5.25	2.25	1.50
rectal cancer cell line:TT1TKB	10469-106I1	43.06	3.20	0.87	1.45
rectum, fetal, donor1	10067-101I4	105.72	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	74.20	3.39	2.12	4.88
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	100.65	3.31	4.56	3.73
retina, adult, pool1	10030-101E3	66.20	3.18	1.29	1.19
retinoblastoma cell line:Y79	10475-106I7	47.02	2.34	0.78	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	40.20	2.09	1.35	2.83
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	89.42	4.22	3.94	7.31
sacrococcigeal teratoma cell line:HTST	10695-109G2	75.03	3.79	0.76	0.76
salivary acinar cells, donor1	11771-123I7	67.66	1.29	1.62	0.81
salivary acinar cells, donor2	11772-123I8	64.58	1.38	0.83	1.24
salivary acinar cells, donor3	11773-123I9	66.21	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	84.08	1.72	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	61.29	2.53	1.94	2.19
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	59.36	4.11	2.70	2.94
seminal vesicle, adult	10201-103F3	55.02	1.59	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	82.11	2.92	2.67	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	79.01	4.28	5.03	7.30
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	79.28	3.01	4.01	8.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	42.18	1.61	0.94	1.75
signet ring carcinoma cell line:Kato III	10436-106E4	60.46	1.99	1.88	1.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	94.58	3.87	2.71	2.97
skeletal muscle - soleus muscle, donor1	10282-104F3	90.79	8.51	1.42	1.42
skeletal muscle, adult, pool1	10023-101D5	79.76	4.80	1.44	1.44
skeletal muscle, fetal, donor1	10066-101I3	58.29	3.02	3.02	4.02
skin, adult, donor1	10074-102A2	108.56	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	83.32	3.16	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	87.38	5.00	6.67	6.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	71.24	3.15	2.52	2.52
small cell lung carcinoma cell line:DMS 144	10841-111E4	59.37	9.25	4.43	5.78
small cell lung carcinoma cell line:LK-2	10541-107H1	87.69	3.30	1.65	3.63
small cell lung carcinoma cell line:NCI-H82	10842-111E5	136.72	5.79	4.99	7.24
small cell lung carcinoma cell line:WA-hT	10562-108A4	114.62	4.79	4.36	4.14
small intestine, adult, pool1	10024-101D6	96.63	2.39	2.75	1.19
small intestine, fetal, donor1	10064-101I1	87.71	6.63	3.93	3.69
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	56.93	1.03	0.00	2.56
smooth muscle, adult, pool1	10048-101G3	56.08	2.84	0.26	1.03
somatostatinoma cell line:QGP-1	10781-110G7	68.35	1.61	1.07	0.54
spinal cord - adult, donor10196	10181-103D1	36.48	3.21	1.38	1.61
spinal cord, adult, donor10252	10159-103A6	37.06	5.91	0.79	1.58
spinal cord, adult, donor10258	10369-105F9	38.74	0.00	2.77	0.69
spinal cord, fetal, donor1	10056-101H2	82.94	3.66	3.05	1.83
spinal cord, newborn, donor10223	10359-105E8	44.08	3.67	3.67	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	57.65	4.63	5.08	2.54
spleen, adult, pool1	10025-101D7	40.75	1.32	0.77	0.55
spleen, fetal, pool1	10044-101F8	41.95	1.59	0.79	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	52.69	2.59	3.62	4.45
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	82.98	1.33	1.33	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	83.87	1.75	1.75	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	175.53	5.08	5.86	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	138.45	9.12	2.48	1.91
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	135.55	8.90	5.51	4.66
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	96.88	3.38	2.54	4.65
stomach, fetal, donor1	10062-101H8	89.71	4.27	2.14	2.14
submaxillary gland, adult	10202-103F4	63.23	0.00	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	41.33	3.12	1.45	1.04
substantia nigra, adult, donor10258	10371-105G2	43.97	0.00	1.55	2.59
substantia nigra, newborn, donor10223	10358-105E7	46.63	1.41	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	56.17	5.27	2.06	2.75
temporal lobe, adult, pool1	10031-101E4	42.30	2.80	1.78	2.03
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	86.90	3.56	2.85	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	69.89	2.64	1.32	2.20
tenocyte, donor1	11763-123H8	76.80	2.44	1.75	2.44
tenocyte, donor2	11765-123I1	64.86	3.05	0.76	1.91
tenocyte, donor3	11768-123I4	68.20	2.97	5.56	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	118.12	4.08	6.46	6.46
teratocarcinoma cell line:NCR-G1	10798-110I6	72.60	2.62	3.85	2.77
teratocarcinoma cell line:PA-1	10807-111A6	83.22	2.94	4.80	2.32
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	73.76	3.17	3.43	2.79
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	93.41	9.08	9.08	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	88.99	1.74	0.65	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	70.03	2.28	2.28	0.33
testis, adult, pool1	10026-101D8	50.79	6.12	16.21	10.31
testis, adult, pool2	10096-102C6	74.43	7.67	34.73	23.46
thalamus - adult, donor10196	10168-103B6	39.74	1.10	3.31	1.10
thalamus, adult, donor10252	10154-103A1	40.95	4.38	1.25	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.33	2.47	1.48	1.98
thalamus, newborn, donor10223	10366-105F6	51.78	4.03	5.75	2.88
throat, adult	10209-103G2	67.41	3.25	1.75	0.50
throat, fetal, donor1	10061-101H7	86.84	2.44	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	50.68	4.57	0.99	1.59
thymus, adult, pool1	10027-101D9	53.58	1.09	0.60	0.50
thymus, fetal, pool1	10043-101F7	71.69	1.97	1.25	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	65.42	5.45	2.26	3.19
thyroid carcinoma cell line:TCO-1	10783-110G9	87.31	4.19	2.93	5.03
thyroid, adult, pool1	10028-101E1	72.69	2.05	1.21	0.75
thyroid, fetal, donor1	10060-101H6	69.08	2.64	2.90	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	0.00	0.00	0.00
tongue, adult	10203-103F5	79.08	3.95	1.63	0.93
tongue, fetal, donor1	10059-101H5	130.05	8.67	2.36	1.97
tonsil, adult, pool1	10047-101G2	60.01	2.20	1.40	0.70
trachea, adult, pool1	10029-101E2	55.95	2.04	1.55	1.31
trachea, fetal, donor1	10058-101H4	78.09	3.46	2.69	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	69.08	2.83	5.67	4.61
transitional-cell carcinoma cell line:5637	10418-106C4	51.57	2.13	2.33	3.04
transitional-cell carcinoma cell line:JMSU1	10492-107B6	93.54	5.48	3.60	4.07
tridermal teratoma cell line:HGRT	10694-109G1	104.64	9.51	1.90	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	82.20	2.71	2.12	2.12
umbilical cord, fetal, donor1	10057-101H3	60.51	2.09	0.00	2.09
uterus, adult, pool1	10100-102D1	71.49	1.54	0.34	1.71
uterus, fetal, donor1	10055-101H1	73.72	2.56	0.00	2.05
vagina, adult	10204-103F6	51.05	5.82	1.29	1.29
vein, adult	10191-103E2	56.99	1.32	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	46.73	1.60	2.67	1.60

Property "Nearest transcripts" (as page type) with input value "ENST00000480908.1:46 AK311982:46 ENST00000393000.3:66 ENST00000273480.4:67 NM_183237.3:67 NM_001201370.2:67 NM_014245.5:67 NR_037703.2:67 NR_037702.2:67 ENST00000477012.5:73 BC008627:75 BC005966:85 AF164679:86 ENST00000477393.1:88 DQ891759:102 DQ894943:102 AB590187:107 KJ892818:110 KJ898056:110 AK289894:111 BT007348:111 AF142060:111 AF312226:111 AF092878:111 ENST00000648835.1:243" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.